This is a summary page co-ordinating cancer and cancer mimics.
I use the following classification systems:
Body System
Life Cycle
Specialty
Histology
Definition
Genetic damage to cell's DNA causing damage to cell reproductive cycle and
Damage to host
Monoclonal vs Polyclonal
All cancers involved a genetic mutation to a cell's DNA. In monoclonal cancers, this single cell multiplies uncontrollably and all subsequent cancer cells are clones. Therefore if a biopsy of the cancer is obtained the results of the genetic and cell analysis will be applicable to all of the cancer cells in the body.
As a cancer progresses it can become polyclonal. Due the excessive number of replications, further mistakes can be made and new cell lineages emerge. Naturally polyclonal cancers are harder to treat due to the diversity of damaged cells.
Some cancers are naturally polyclonal. For example the prostate may have many individual monoclonal cancers, which can collectively be thought of as polyclonal.
Grade and Severity
There are some core severity markers associated with the cell abnormalities and clinical presentation.
Cell
Level of differentiation
Genetic profile- presence of multiple DNA mutations
Clinical presentation
Short history/ quick doubling speed
Metastatic spread
Younger age suggests more abnormal and resistant cancer to natural immune system guards
Cancer's and their growth's are usually named via their site of damage or site of primary.
The 12 body systems & specialties involved, excluding oncology, palliative & paediatrics.
Nervous: (Neurology)
Primary: Gliobastoma, Meningioma, Astrocytoma
Metastatic Cancer
Spinal Cord Cancer
Peripheral nervous cancers: Tuberous Sclerosis, Neurofibromatosis
Endocrine (Endocrinology)
Phaeochromocytoma, Thyroid cancer, Multiple endocrine neoplasia, Carcinoid syndrome, Paraneoplastic cancers
Senses
Ophthalmology: retinoblastoma
ENT: head & neck cancer
Cardiovascular (Cardiology, cardiothoracic)
Respiratory (Respiratory, cardiothoracic)
Lung cancer- small cell and non small cell
GI (Gastroenterology, general surgery)
Oesphagus, Stomach, Colorectal, Anal cancers
Pancreas, Liver, Gallbladder
Urinary (Renal, urology)
Repro female (Gynaecology)
Breast, ovarian, cervical, vulva cancers
Repro male (Urology)
Testicular, Prostate, Penile cancers
Haematopoietic (Haematology)
Lymphoid: ALL, CLL; Lymphoma, myeloma, amyloidosis
Myeloid
Myeloproliferative: Polycythaemia vera, essential thrombocytosis, myelofibrosis,
Myelodysplastic disorders (MDS)
Musculoskeletal (Orthopaedics, rheumatology)
Sarcoma, Osteoblastoma
Skin (Dermatology)
Malignant melanoma, Squamous cell carcinoma, Basal cell carcinomas
Life cycles
Neonates Retinoblastoma
Paediatrics Wilms tumour, ALL
Adult Medicine Breast, cervical, testicular, lymphoma, ovarian
Medicine of the Elderly Prostate, colorectal, breast, lung
Palliative Care Lung, colorectal, breast, ovarian, pancreatic..
By Aetiology
Genetic
All cancers, retinoblastoma, CRC, breast cancer
Environment
Chemical Trauma
Skin cancer, lung cancers, mesothelioma
Infections: bladder cancer
By Histology
Adenocarcinoma
Esophageal, gastric and colorectal cancer
Prostate cancer
Lung cancer in non smokers
Squamous cell carcinoma
Lung cancer (hyper calcaemia)
Skin cancer: SCC
Cervical cancer
Small cell: lung cancer
Grossly differentiated (unknown)
Management
Analgesia
Bisphosphonates
External beam radiotherapy
Spinal cord compression
Raised ICP
Ascites or pleural effusion
Hyperviscosity syndrome
Biomarker Cancer associated
Ca125 Ovarian cancer
Ca19-9 Biliary & pancreatic cancer
Ca15-9 Breast cancer
CEA Colorectal cancer
AFP Testicular (non-seminoma), hepatocellular cancer, teratomas
HCG Seminomas
Page written in 2024.